Shin-ichi Ohnuma,John Daniel Kelly,Ryuji Hamamoto,Julie Watson
申请号：
US13516749
公开号：
US20120304318A1
申请日:
2010.12.17
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The invention concerns materials and methods relating to the use of OMD (osteomodulin) and\or PRELP (Proline/arginine-rich end leucine-rich repeat protein) expression, particularly under-expression, to discriminate cancer and non-cancer cells in a variety of cancers. The invention further provides methods and materials based on OMD and\or PRELP for use in therapy e.g. to suppress cancer initiation or development.
